The diagnosis of seronegative antiphospholipid syndrome (APS) has been proposed for patients with well-defined clinical APS but persistently negative for the routinely tested antiphospholipid antibodies (aPLs): antibodies to cardiolipin (aCL) and to β2 glycoprotein I (aβ2GPI) and lupus anticoagulant (LA). Antibodies directed to phosphatidylethanolamine (aPE) have been described as the sole aPLs in some patients with clinical manifestations of APS. Here, we briefly summarize the available data on the clinical associations of aPEs and propose their investigation in patients with a clinical profile highly suggestive of seronegative APS.
GrisJCQuéréISanmarcoM. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early fœtal loss. Thromb Haemost2000; 84: 228–236.
2.
SugiTMatsubayashiHInomoADanLMakinoTJ. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. Obstet Gynaecol Res2004; 30: 326–332.
3.
Gonzales-PortilloFMcIntyreJAWagenknechtDRWilliamsLSBrunoABillerJ. Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease. J Stroke Cerebrovasc Dis2001; 10: 222–226.
4.
SanmarcoMAlessiMCHarleJR. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb Haemost2001; 85: 800–805.
5.
SanmarcoMGayetSAlessiMC. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost2007; 97: 949–954.
6.
SanmarcoMBoffaMC. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome. Lupus2009; 18: 920–923.
7.
VelayuthaprabhuSMatsubayashiHSugiT. A unique preliminary study on placental apoptosis in mice with passive immunization of anti-phosphatidylethanolamine antibodies and anti-factor XII antibodies. Am J Reprod Immunol2011; 6: 373–384.
8.
SanmarcoM. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results. J Immunol Methods2010; 358: 9–16.
9.
SugiTMclntyreJA. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Thromb Haemost1996; 76: 354–360.
